The mayor conducted the inspection at The Lalit Hotel in Andheri East, during which some Brihanmumbai Municipal Corporation officials accompanied her.
With 1,421 new coronavirus infections being reported in a day, India's total tally of COVID-19 cases rose to 4,30,19,453, while the active cases dipped to 16,187, according to the Union health ministry.
An expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage just two days ago, officials said.
Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV). The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the country's first and only Phase III efficacy study for a COVID-19 vaccine, a press release from the vaccine maker said on Saturday night.
The active cases declined to 5,72,994 comprising 1.89 per cent of the total infections, while the national COVID-19 recovery rate has improved to 96.80 per cent, the data updated at 8 am showed.
The active cases constitute 0.05 per cent of the total infections.
Jadhav said the country should have followed the WHO guidelines and prioritised vaccination accordingly.
Will syringe shortage puncture India's Covid vaccine plans?
'...What is at stake, however, is his ability to assess the need for vaccinations or whether the vaccine has been tested for a sufficient period of time. And ... he has neither the knowledge nor the studies nor the research work that would allow him to form an opinion about it.'
Over one crore COVID-19 vaccine doses have been administered in the country till now with the highest single-day vaccinations of more than 6 lakh jabs given on Thursday, the Union health ministry said on Friday.
The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive.
The daily positivity rate was recorded at 2.72 per cent. It has been less than three per cent for the last 11 days.
While there has been no commitment from the government on the procurement of vaccines, initial volumes, or distribution plans, there is a likelihood that the low interest loans may be made available to these players only when the time to scale up manufacturing arises.
Yeh Hai India: Capturing the events and moods across our incredible country.
This is for the first time that Maharashtra is going through such "worst situation", she said, and held the Union government responsible for it.
Some residents also wondered if this was a bid to "divert people to private hospitals" for paid jabs rather than getting free vaccine doses at government centres.
The Pune-based Gennova Biopharmaceuticals has submitted phase 2 data of mRNA vaccine and has also completed the recruitment of phase 3 data.
Providence will sell up to 30 mn doses of its mRNA vaccine to Biological E. It would also provide the necessary technology transfer to make the vaccine in India, with a minimum production capacity of 600 mn doses in 2022 and targets capacity of 1 bn doses, reports Sohini Das.
The number of people who have recuperated from the disease surged to 1,06,11,731 which translates to a national COVID-19 recovery rate of 97.31 per cent, while the COVID-19 case fatality rate stands at 1.43 per cent.
Many inoculation centres in Maharashtra are being shut due to the shortage of coronavirus vaccine, Health Minister Rajesh Tope said on Wednesday, adding the state now has 14 lakh doses which would last just three days.
While the Indian government has been procuring Covid-19 vaccines at low prices so far, manufacturers have to declare the prices of vaccines they would supply to the open market (industries, private hospitals, etc) and state governments before May 1. Sohini Das reports.
"We have started the phase-III trials of the vaccine (candidate Covishield). We will administer dose to 150 to 200 volunteers," said Dr Muralidhar Tambe, Dean, Sassoon General Hospital.
Pune-based Serum Institute of India (SII) is sitting on 200 million doses of Covishield that were manufactured in December and are set to expire in September. The company is likely to destroy these vaccines if nothing works out, Sohini Das reports.
The number of deaths reported on Friday is the highest since October 26 last year, when 37 persons had died, the data shared by the civic body said.
The results were the same in seniors, with a median age of 76, and caregivers, with a median age of 48, and old alike, according to the researchers.
Tamil Nadu, Haryana, Punjab, Manipur and Telangana report the most wastage.
The daily positivity rate dropped to 3.22 per cent. It has been less than five per cent for nine consecutive days, the ministry said, adding the weekly positivity rate has declined to 4.17 per cent.
Microsoft Chairman and CEO Satya Nadella along with Alphabet Inc and its subsidiary Google CEO Sundararajan Pichai are also among those from trade and industry who have been awarded the Padma Bhushan for their distinguished services.
Recoveries outnumbered daily new cases for the 32nd consecutive day in the country.
Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories.
US President Joe Biden on Wednesday announced that the US will allocate 75 per cent - nearly 1.9 crore of the first tranche of 2.5 crore doses - of unused COVID-19 vaccines from its stockpile through the UN-backed COVAX global vaccine sharing programme to countries in South and Southeast Asia as well as Africa.
A departmental notice dated December 15, 2020, stated that the cooperation of officers and employees of the directorate general will be needed during the proposed coronavirus vaccination.
India has the capacity to store vaccines that may require a lower temperature in the range of -15 to -20 degrees Celsius and there are over 29,000 cold chain points (CCPs) across the country where vaccines are stored at the recommended temperatures, the Centre has told the Supreme Court.
With the fresh cases, the total tally of COVID-19 cases rose to 4,29,93,494. On May 3, 2020, 2,487 cases were recorded.
At 4.35 pm, a tweet from the verified Twitter handle of the Aarogya Setu mobile application said the CoWIN portal is working and that there was a minor glitch at 4 pm, which was fixed.
'Many of them were scared. So, I went to my seniors and said I should be given the vaccine first. I wanted to prove to my colleagues that there is no need to be scared'
According to The New York Times, this move means that many highly vulnerable people will begin receiving the vaccine within days. It further called the authorisation by the FDA as a 'historic turning point' as the US death toll from the Wuhan-originated virus nears 300,000.
As the largest producer of vaccines in the world, with 60 per cent of the global share, India is well-positioned to use its existing manufacturing capabilities to contribute to mass vaccine production and distribution needs for other countries in addition to meeting its domestic requirements, said Moody's.
The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals. The Pune-based Serum Institute of India, the world's largest vaccine maker in terms of volume, has announced a price of Rs 400 per dose for its COVID-19 vaccine, 'Covishield', for state governments and Rs 600 per dose for private hospitals.
The death toll climbed to 5,24,636 with six fatalities, the data updated at 8 am stated.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances